C12Y 301/11001
Exodeoxyribonuclease i
Official title: Exodeoxyribonuclease I (3.1.11.1)
C12Y301/11001 (Exodeoxyribonuclease i) appears on 4 US grants and 12 published applications in this corpus.
Search patents in C12Y- Granted patents
- 4
- Published applications
- 12
- Assignees
- 8
- Inventors
- 38
- Latest grant
- 24 Jan 2023
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2016 | 0 | 1 |
| 2017 | 0 | 1 |
| 2018 | 1 | 1 |
| 2019 | 1 | 0 |
| 2020 | 1 | 2 |
| 2021 | 0 | 1 |
| 2022 | 0 | 1 |
| 2023 | 1 | 0 |
| 2024 | 0 | 3 |
| 2025 | 0 | 0 |
| 2026 | 0 | 2 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Fusion moieties and microbial hosts for protein production24 Jan 2023US 11,560,582 B2Universitetet I Tromsø—Norges Arktiske Universitet
- Thermolabile exonucleases29 Sep 2020US 10,787,702 B2Arcticzymes AS
- Thermolabile exonucleases17 Sep 2019US 10,415,082 B2Arcticzymes AS
- Thermolabile exonucleases2 Oct 2018US 10,087,483 B2Arcticzymes AS
- Strand Displacement-Based Gene Editing Method and System and Use Thereof17 Sep 2026US 2026/0275310 A1
- Compositions and methods for modulating cxcl9, cxcl10, and cxcl11 gene expression2 Jul 2026US 2026/0183426 A1Flagship Labs 114, Inc.
- Linear dna with enhanced resistance against exonucleases and methods for the production thereof31 Oct 2024US 2024/0360488 A1
- Compositions and methods for site-directed mutagenesis10 Oct 2024US 2024/0336904 A12seventy bio, Inc.
- High definition molecular array feature generation using photoresist7 Mar 2024US 2024/0076656 A110x Genomics, Inc.
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.